Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis has demonstrated benefits of an investigational, once-a-day pill called brenso catib as ...

Insmed has claimed the distinction of becoming the first company to get FDA approval for a treatment for chronic lung disease non-cystic fibrosis bronchiectasis (NCFB). The US regulator cleared DPP1 ...

The list of new medicines recommended for approval at the October meeting of the EMA's human medicines committee includes Brinsupri, the first treatment for serious chronic lung disease non-cystic ...

The Cystic Fibrosis Foundation organised a multidisciplinary committee to develop this Position Paper to outline current ...

Screen Australia has released a new Private Investment Toolkit for screen producers and potential investors, with the intention of bridging knowledge gaps between these major screen industry ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Use our currency converter to find the live exchange rate between AUD and USD. Convert Australian Dollar to United States Dollar ...

UNESCO and the Advisory Bodies to the World Heritage Committee have issued new guidance for assessing impacts from projects that could potentially affect the planet’s most precious heritage places.

Use our currency converter to find the live exchange rate between USD and AUD. Convert United States Dollar to Australian Dollar ...

Three decades ago near Ipswich, Malaysian-born entrepreneur Maha Sinnathamby stumbled across an unloved 2860-hectare swath of ex-forestry land. His property developer business partner, Bob Sharpless, ...

The World Bank Group’s Crisis Preparedness and Response Toolkit enables countries to respond faster to crisis, protect development gains, and build resilience in a world where crises have become the ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Doug Mahoney Doug Mahoney is a writer covering home-improvement topics, ...